Puig, L, Carrascosa, JM, Rivera, R, Vilarrasa, E, de la Cueva, P, López-Ferrer, A. Generalized Pustular Psoriasis: Review and Consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Actas Dermo-Sifiliograficas. 2026; 117(3)DOI:10.1016/j.ad.2025.104544. PMID:41371399. IF:(Q/D).

Mansilla-Polo, M, Pons-Benavent, M, Fernández-Crehuet, P, Vilarrasa, E, Albanell-Fernández, C, Morales-Tedone, E, Rausell-Félix, F, Alcalá-Garcia, R, Matellanes-Palacios, M, Martin-Ezquerra, G, Alfageme, F, Ciudad-Blanco, C, López-Villaescusa, MT, Segura-Palacios, JM, Pascual-Ramirez, JC, Fernández-Diaz, ML, Falkenhain-López, D, Garcia-Gil, M, Agusti-Mejias, A, No-Pérez, N, Naranjo-Guerrero, N, Estenaga-Pérez, A, Garcia-Ruiz, R, Mahiques-Santos, L, Garbayo-Salmons, P, Martorell, A, Escutia-Muñoz, B, Martin-Torregrosa, D, Cuenca-Barrales, C, Paniego, CU, Botella-Estrada, R, Molina-Leyva, A. Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study. Actas Dermo-Sifiliograficas. 2026; 117(3)DOI:10.1016/j.ad.2025.104531. PMID:41354335. IF:(Q/D).

Grau-Pérez, M, Mercader-García, P, Giménez-Arnau, AM, Sanz-Sánchez, T, Ninet, VZ, Guijarro, SC, Miquel, FJM, Salvador, JFS, González-Pérez, R, González, IR, Baldrich, ES, Carrascosa, JM, de Frutos, FJO, Serna, MR, Ortega, MEG, Suárez, CP, Triviño, FJN, Chicharro, P, Andreu, M, Gilo, AS, Rodríguez, JJP, Nieto, MAP, Melé-Ninot, G, Guillén, PS, de la Fuente, EG, Elosua-González, M, Munera-Campos, M, Romero, FT, Descalzo, MA, Borrego, L. Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019-2024. CONTACT DERMATITIS. 2026; 94(3)DOI:10.1111/cod.70048. PMID:41365615. IF:4.600(Q1/1D).

Calvo-Río, V, Secada-Gómez, C, Gutiérrez, AM, Retuerto-Guerrero, M, Font, J, Casafont-Solé, I, Mayo-Juanatey, A, Sancho, JJA, Freites, D, Hormigos, C, Puñal, NG, Arribas, GG, Sanchez, JRM, García-Valle, A, Ibañez, M, Morillo, FL, Manzanares, AG, Sandoval-Moreno, S, Cortes-Hernandez, J, Sanchez, DP, Lojo, L, Pérez, ECC, Collado, P, Larios, CA, Icardo, LS, Labrador-Sánchez, E, Peralta-Ginés, C, Onaindia, IU, Plaza-Aulestia, N, Malone, MM, de Salazar, JRG, Corteguera, M, Cebrián-Méndez, L, Pages, FAA, Riazuelo, JRL, Canales, MDF, Hernández, MJA, Bufort, MG, Pàmies, A, de Ardanaz, LS, Aguirre-del-Pino, R, Lefler, JAC, Seijas-Lopez, A, Cubero, MDC, Cofiño, ALC, Ortiz-Santamaria, V, Piñeiro, ML, Calvo, CO, Lopez, CA, Urruticoechea-Arana, A, Magallon, BG, Alfaro, AVA, Rodriguez, SL, Olivares, MS, Villar, PL, Brandy-García, AM, Vilamajo, IR, Martos, AG, Lopez, BPM, Urmeneta, GS, Martín, CC, Riera, E, Bejerano, C, Castañeda, S, Blanco, R. Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review. RMD Open. 2026; 12(1)DOI:10.1136/rmdopen-2025-006549. PMID:41856562. IF:4.700(Q1/1D).

Agmon-Levin, N, Ignatenko, S, Gordienko, A, Cortés-Hernández, J, Narongroeknawin, P, Romanowska-Próchnicka, K, Shen, N, Ciferska, H, Kodera, M, Cheng-Chung, WJ, Leszczynski, P, Lan, JL, Mysler, E, Wojciechowski, R, Tarr, T, Vishneva, E, Chen, YH, Kaneko, Y, Finzel, S, Hoi, A, Okada, M, Koolvisoot, A, Lee, SS, Lie, D, Kaneko, H, Rojkovich, B, Sun, LY, Zotkin, E, Viallard, JF, López, BPM, Ghanshani, SA, Lau, C, Avrameas, A, Sips, C, Oliver, SJ. B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment. ANNALS OF THE RHEUMATIC DISEASES. 2026; 85(3)DOI:10.1016/j.ard.2025.11.015. PMID:41353079. IF:20.600(Q1/1D).

Loricera, J, Molina-Collada, J, Nieto, JC, Sánchez-Lucas, M, Silva-Díaz, MT, Moya, P, Labrador, E, Ferraz-Amaro, I, Blanco, R. Switching from Originator Tocilizumab to Biosimilar in Giant Cell Arteritis: Evaluation of Effectiveness and Safety in a Multicenter Cohort of 38 Patients. DRUGS & AGING. 2026; 43(3)DOI:10.1007/s40266-026-01281-1. PMID:41714460. IF:3.800(Q2/3D).

Dominguez-González, C, Romero, MAB, Eraso, CC, de las Heras, J, Muñoz, EF, Garcia-Campos, O, González, M, Grau, JM, Hernández-Voth, A, Morales, RJ, Hernández, JCL, Martos, ML, López-Padilla, D, Muelas, N, Nascimento, A, Olivé, M, Paradas, C, Fernández, JP, Pascual, SI, Pitarch, I, Sancho, J, Diaz-Manera, J. Recommendations for the diagnostic, treatment, and follow-up of late-onset Pompe disease. NEUROLOGIA. 2026; 41(2)DOI:10.1016/j.nrl.2025.501933. PMID:41453611. IF:3.100(Q2/4D).

Doneddu, PE, Collet-Vidiella, R, Gallo, C, Cocito, D, Manganelli, F, Falzone, Y, Dalla Bella, E, Benedetti, L, Mazzeo, A, Peci, E, Spina, E, Strano, C, Germano, F, Gentile, L, Liberatore, G, Cutellè, C, Bianchi, E, Querol, L, Nobile-Orazio, E. Effect of Rituximab on Neurofilament Levels in CIDP: Results From the CIDPRIT Randomized Trial. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2026; 31(1)DOI:10.1111/jns.70107. PMID:41649095. IF:3.200(Q2/4D).